Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Astrazeneca, Blade, Calliditas, Celltrion, Celularity, Corvus, Cyxone, Daiichi Sankyo, Diffusion, Eli Lilly, Humanigen, Inflarx, Kamada, Octapharma, Pfizer, Pharmabcine, Recce, Regeneron, Sinovac, Seneca, Takeda, Verona.